Catalyst Wire Dossier Catalyst Wire Dossier

BROMPHENIRAMINE, PSEUDOEPHEDRINE, DEXTROMETHORPHAN

brompheniramine, pseudoephedrine, dextromethorphan · Ascend Laboratories, LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BROMPHENIRAMINE, PSEUDOEPHEDRINE, DEXTROMETHORPHAN, covering 2020-07-14 to 2020-07-14. Get the full timeline:

Most recent: FDA Approved: BROMPHENIRAMINE, PSEUDOEPHEDRINE, DEXTROMETHORPHAN — Original Application (Ascend Laboratories, LLC)

See pricing